A Tolerability and Pharmacokinetic Study of Adjuvant Erlotinib and Capecitabine with Concurrent Radiation in Resected Pancreatic Cancer-Reference-Cited by-同舟云学术

A Tolerability and Pharmacokinetic Study of Adjuvant Erlotinib and Capecitabine with Concurrent Radiation in Resected Pancreatic Cancer

Published:2010-12 Issue:6 Volume:3 Page:373-379
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Ma Wen Wee,Herman Joseph M.,Jimeno Antonio,Laheru Daniel,Messersmith Wells A.,Wolfgang Christopher L.,Cameron John L.,Pawlik Timothy M.,Donehower Ross C.,Rudek Michelle A.,Hidalgo Manuel

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference46 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial;Regine;JAMA,2008

3. Adjuvant therapy for pancreatic cancer: a review;Zuckerman;Cancer,2008

5. Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer;Mackean;J Clin Oncol,1998

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance;Cell Reports;2024-07

2. Erlotinib combination with a mitochondria-targeted ubiquinone effectively suppresses pancreatic cancer cell survival;World Journal of Gastroenterology;2024-02-21

3. Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance in a p53-dependent manner;2023-01-02

4. Does Erlotinib Restore Chemosensitivity to Chemotherapy in Pancreatic Cancer? A Retrospective Analysis;J PANCREAS;2022

5. Clinical and Preclinical Outcomes of Combining Targeted Therapy With Radiotherapy;Frontiers in Oncology;2021-10-18